As obesity expands waistlines in the Western world, a silent killer linked to the condition nicknamed "human foie gras" is spurring a potential bonanza worth billions for drugs giants.
The disease, formally known as non-alcoholic steatohepatitis (NASH), is caused by a buildup of fat in the liver. It is already the leading ailment cited in requests for liver transplants in the United States, Cecile Rabian of France's Gilead laboratory told AFP.Full Story
Long-term, daily use of aspirin to prevent blood clots in very elderly patients leads to an increased risk of serious or fatal internal bleeding, researchers said Wednesday.Full Story
A mass food poisoning at a camp for displaced Iraqi civilians outside Mosul has left hundreds of people requiring urgent treatment, the U.N. and Iraqi officials said Tuesday.Full Story
At Yemen's Sabaeen Hospital, code black is an understatement: patients sleep three to a bed, on the bare floor or outside in tents as cholera brings a country torn by war to its knees.Full Story
An anti-diabetic drug that lowers blood sugar levels for type 2 diabetes sufferers also significantly cuts the risk of cardiovascular and kidney disease, according to a study published Monday.Full Story
Ken Shefveland's body was swollen with cancer, treatment after treatment failing until doctors gambled on a radical approach: They removed some of his immune cells, engineered them into cancer assassins and unleashed them into his bloodstream.
Immune therapy is the hottest trend in cancer care and this is its next frontier — creating "living drugs" that grow inside the body into an army that seeks and destroys tumors.Full Story
Three new cases of polio have been recorded in Syria in the first outbreak of the virus in the country since 2014, the World Health Organization and a partner initiative said.Full Story
Even moderate drinking is linked to brain damage and a slight decline in mental skills, according to a study released Wednesday that calls into question many national alcohol guidelines.Full Story
In Mali, where skin conditions are widespread and skin doctors are scarce, physicians have turned to technology to treat patients remotely.
From his Bamako office, Professor Ousmane Faye, one of a small number of dermatologists in Mali, examines photos of an arm and a torso afflicted by a skin pigmentation disorder.Full Story
A new kind of targeted therapy slowed the advance of an aggressive form of lung cancer for about two years, or about three times as long as the standard treatment, researchers said Monday.
The Roche-made drug known as alectinib (Alecensa) could become a new tool in the fight against non small cell lung cancer.Full Story